An open-label, randomized, parallel-group, adaptive design with
blinded outcome adjudication trial conducted to compare the
efficacy and safety of milvexian and enoxaparin in patients
undergoing elective knee arthroplasty.
About the Podcast
Season-3 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.